|
Volumn 23, Issue 4 SUPPL. 1, 2002, Pages
|
Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease
|
Author keywords
Alzheimer's disease; COX 2 selective inhibitors; Coxibs; Rofecoxib
|
Indexed keywords
AZATHIOPRINE;
BETA INTERFERON;
COLCHICINE;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
DAPSONE;
DICLOFENAC;
DONEPEZIL;
ETANERCEPT;
GALANTAMINE;
GLUCOCORTICOID;
IBUPROFEN;
INDOMETACIN;
INFLIXIMAB;
METHOTREXATE;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PREDNISONE;
RIVASTIGMINE;
ROFECOXIB;
SALAZOSULFAPYRIDINE;
TACRINE;
ALZHEIMER DISEASE;
ANTIINFLAMMATORY ACTIVITY;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFERENCE PAPER;
DRUG EFFECT;
HUMAN;
INFLAMMATION;
NERVE DEGENERATION;
NEUROPROTECTION;
PROPHYLAXIS;
REGULATORY MECHANISM;
TOXICITY;
TREATMENT OUTCOME;
AGED;
ALZHEIMER DISEASE;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
|
EID: 0036242939
PISSN: 08853924
EISSN: None
Source Type: Journal
DOI: 10.1016/S0885-3924(02)00374-3 Document Type: Conference Paper |
Times cited : (71)
|
References (42)
|